Dataset from An Exploratory, Randomized, Double-Blind, Crossover Study to Compare the Efficacy and Safety of BIIB074 Versus Placebo in the Treatment of Primary Inherited Erythromelalgia
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00009296
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study is to investigate the efficacy of repeat oral dosing of
BIIB074 on paroxysmal pain in participants with Primary Inherited Erythromelalgia (EM). The
secondary objective of the study is to investigate the efficacy of repeat oral dosing of
BIIB074 on varying additional aspects of pain in participants with EM; and to investigate the
safety and tolerability of repeat oral dosing of BIIB074 in participants with EM.
创建时间：
2025-10-05
